openPR Logo
Press release

Biobanking Market size to reach $60.37 Billion by 2035 | Key players include Thermo Fisher Scientific, Merck KGaA, Qiagen N.V., Brooks Life Sciences, Hamilton Company

12-04-2025 12:33 PM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

Biobanking Market

Biobanking Market

Market Outlook and Forecast

Biobanking Market is experiencing strong expansion as organizations deepen their focus on translational research, genomic sequencing, biomarker discovery, and stem cell applications.

In 2025, the market size stands at USD 26.7 billion, reflecting robust demand for structured biospecimen repositories and enhanced sample preservation solutions. This growth is supported by rising prevalence of chronic diseases, expanded genomic research funding, and adoption of biobanking technologies by pharmaceutical and biotechnology industries.

By 2035, the Biobanking Market is projected to reach USD 60.37 billion, driven by advancements in storage automation, AI-powered sample tracking systems, integration of electronic laboratory notebooks (ELN), and expansion of population-based biobanks. The global market is expected to grow at a CAGR of 8.5% from 2026-2035, highlighting the sector's long-term strategic significance in medical research and innovation.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-4602

Regional Performance Highlights

North America is expected to maintain its leadership, securing 40.8% market share by the end of 2035. The region benefits from advanced research infrastructure, robust biotechnology investments, government-led genomic initiatives, and the presence of large-scale commercial biobanks. Strong collaborations between academic institutions, biopharma companies, and research organizations further enhance market growth.

Europe holds the second-largest share of the global Biobanking Market, supported by extensive biomedical research programs, EU-funded genomic initiatives, and long-standing population biobanks in countries such as the U.K., Sweden, and Germany. The region's focus on ethical data governance, sustainability in biobanking operations, and cross-border research collaborations continues to drive adoption.

Asia Pacific represents a fast-growing region due to rising healthcare investments, expansion of genome sequencing programs, and increasing clinical research activities in China, India, Japan, and South Korea. Growing prevalence of lifestyle-related diseases and increased participation in international research consortia are accelerating the need for high-quality biobanking services and advanced storage solutions.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Biobanking Market Report Overview here: https://www.researchnester.com/reports/biobanking-market/4602

Segmental Insights

Among various product categories, the blood products segment is projected to hold the largest market share over the projected timeframe. Blood-derived biospecimens-including plasma, serum, and whole blood-are extensively used in genomics, oncology research, biomarker discovery, and clinical diagnostics. Their versatility, availability, and wide research applicability make them the most in-demand biospecimen category.

Biobanking serves multiple high-value applications across healthcare, biotechnology, and life sciences:

• Disease Research and Biomarker Discovery: Biobanks play a crucial role in studying rare diseases, cancer progression, immune system disorders, and metabolic diseases.

• Precision Medicine: Genetic data linked with biospecimens enables personalized treatment development and risk profiling.

• Drug Discovery and Development: Pharmaceutical companies rely on large biobank datasets for identifying therapeutic targets and validating drug responses.

• Regenerative Medicine and Stem Cell Research: Stem cell biobanking supports tissue engineering, cell therapies, and regenerative applications.

• Clinical Trials: Biobanks streamline sample collection, storage, and retrieval for multi-phase clinical studies.

The increasing integration of digital platforms, automated storage systems, and AI-driven data analysis tools further enhances biobank efficiency, scalability, and research output.

➤ Discover how the Biobanking Market is evolving globally - access your free sample report → https://www.researchnester.com/sample-request-4602

Top Market Trends

1. Digital Biobanking and AI-Driven Sample Management

One of the most influential trends is the acceleration of digital biobanking, where AI and automation streamline specimen tracking, data integration, and predictive analytics. AI-enabled systems minimize human error, optimize sample retrieval, and enhance data accuracy. Recent industry shifts include deployment of cloud-based laboratory information management systems (LIMS) that support secure, interoperable data exchange.

2. Growth of Population Biobanks and Genomic Initiatives

Governments and private organizations are expanding large-scale, population-wide biobanks to support genomics-driven healthcare. Initiatives such as national genome sequencing programs and precision medicine projects are enhancing the demand for structured, ethically governed biobanks. Many countries have launched longitudinal data collection programs to accelerate epidemiological and genetic studies.

3. Sustainability in Biobanking Infrastructure

Sustainability has emerged as a key priority, with an increasing push toward energy-efficient freezers, eco-friendly storage facilities, and reduced carbon footprint. Research institutions and biobanks are transitioning to low-energy cryogenic systems and implementing green building certifications to strengthen environmental responsibility. Recent developments highlight industry investments in smart facility management systems that optimize power consumption and cold-chain operations.

➤ Stay ahead of the curve with the latest Biobanking Market trends. Claim your sample report → https://www.researchnester.com/sample-request-4602

Recent Company Developments

Below are five notable company activities shaping the global Biobanking Market over the past 12 months:

1. Thermo Fisher Scientific

Thermo Fisher expanded its biorepository services with new automated sample management solutions and high-capacity cold storage systems. The company invested in digital LIMS platforms and strengthened its global biobanking service network to support pharmaceutical R&D and genomic studies.

2. Merck KGaA
Merck introduced upgraded cryopreservation media and sample stabilization technologies to improve the quality and longevity of biospecimen storage. The company also announced new collaborations with biotech firms to advance clinical research through integrated biobanking solutions.

3. Qiagen N.V.

Qiagen expanded its biobanking product line with new kits designed for nucleic acid stabilization and purification. Recent partnerships with research institutions aim to enhance large-scale genomic workflows and strengthen the company's foothold in precision medicine.

4. Brooks Life Sciences (now Azenta Life Sciences)

Azenta Life Sciences launched next-generation automated storage systems and expanded its global biorepository footprint. The company emphasized investments in robotics, AI-based tracking, and cloud-enabled sample management.

5. Hamilton Company

Hamilton introduced advanced robotics-driven biobanking systems designed to improve accuracy, temperature stability, and operational efficiency. The company also enhanced its integration capabilities with digital lab platforms to support fully automated biobank environments.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-4602

➤ Related News -

https://www.linkedin.com/pulse/what-future-wearable-pregnancy-devices-market-kse9c/

https://www.linkedin.com/pulse/how-artificial-organs-bionic-implants-redefining-wvenf/

Contact Data

AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biobanking Market size to reach $60.37 Billion by 2035 | Key players include Thermo Fisher Scientific, Merck KGaA, Qiagen N.V., Brooks Life Sciences, Hamilton Company here

News-ID: 4300695 • Views:

More Releases from Research Nester Pvt Ltd

Epilepsy Market size to cross $4.02 Billion by 2035 | Stryker B.V., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., Sunovion Pharmaceuticals, Inc.
Epilepsy Market size to cross $4.02 Billion by 2035 | Stryker B.V., Johnson & Jo …
Market Outlook and Forecast The epilepsy market continues to evolve as healthcare systems worldwide prioritize early diagnosis, precision treatment, and improved patient outcomes for neurological disorders. Epilepsy, one of the most prevalent chronic neurological conditions, demands sustained investment in imaging capabilities, therapeutic innovation, and hospital infrastructure. The global market is projected to grow from USD 2.59 billion in 2025 to USD 4.02 billion by 2035, reflecting steady adoption of advanced diagnostic
Global Electronic Chemicals and Materials Market: Top Companies, Market Share Rankings & Investment Insights
Global Electronic Chemicals and Materials Market: Top Companies, Market Share Ra …
The electronic chemicals and materials market has become a central pillar in the global semiconductor, display, and PCB manufacturing ecosystem. As device architectures shrink and functional requirements expand, leading suppliers are shifting from commodity materials to highly engineered chemistries and advanced substrates. This article provides a strategic, competition-focused view of the landscape-analyzing top companies, their positioning, and current investment opportunities-without referencing market sizing or growth projections. ➤ Request Free Sample PDF
Top Companies in the Concentrating Solar Power (CSP) Market - Abengoa, New BrightSource, Ltd., Siemens Energy, ACCIONA, Aalborg CSP A/S
Top Companies in the Concentrating Solar Power (CSP) Market - Abengoa, New Brigh …
The global push for renewable energy, rising demand for dispatchable clean power, and growing emphasis on energy security are bringing renewed attention to the Concentrating Solar Power (CSP) Market. As utilities and governments worldwide increase investments in solar thermal, CSP emerges as a compelling solution-especially for regions with high direct solar irradiance and needs for thermal energy storage. Against this backdrop, several seasoned players and innovative new entrants are vying
Barrier Coated Flexible Paper Packaging Market Dominance: Top Companies Strengthening Share & Investment Appeal
Barrier Coated Flexible Paper Packaging Market Dominance: Top Companies Strength …
Barrier Coated Flexible Paper Packaging Market is undergoing a major transformation as industries accelerate their shift toward recyclable, lightweight, and high-performance packaging solutions. With sustainability regulations tightening and brands prioritizing eco-friendly alternatives to plastic, barrier-coated flexible paper packaging has emerged as a high-impact category. This segment blends the renewable benefits of paper with advanced barrier technologies, enabling protection against moisture, oxygen, grease, and contaminants-while maintaining recyclability. In this strategic analysis, we

All 5 Releases


More Releases for Biobanking

Global Biobanking Services & Biobanking Software Market Size, Share, Growth, Tre …
The Biobanking Services Market has witnessed substantial growth in recent years, driven by increasing investments in research and development activities across the healthcare and life sciences sectors. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and cells, along with associated clinical and genetic data. This market's size is expected to expand significantly in the coming years due to rising demand for personalized
Biobanking Market - Strength in Diversity, Defying Disease: Biobanking Fuelling …
Newark, New Castle, USA: The "Biobanking Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biobanking Market: https://www.growthplusreports.com/report/biobanking-market/7617 This latest report researches the industry structure, sales, revenue, price and
Mexico Biobanking Market Analysis to 2027
Biobanking Market: Overview Transparency Market Research (TMR) has published a new report on the biobanking market for the forecast period of 2019-2027. According to the report, the global biobanking market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Biobanking Market: Overview Growth of the global biobanking market is attributed to an increase in the demand for biobanks in genomics and biomedical research, and rising focus on precision medicine. North America dominated the
Biobanking Market Overview and Regional Outlook Study
Biobanking Market Introduction The term 'biobanking' is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept
Biobanking Market: Rising Impressive Business Opportunities Analysis Forecast by …
(Latest Industry Report 2022) Biobanking Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established manufacturers.
Biobanking Market Industry Trends, Estimation & Forecast, 2017 - 2025
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include a rise in funding support by private & government organizations. Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict market growth. The major factors for the